— 3M Company (NYSE: MMM) reported fourth-quarter 2019 adjusted earnings of $1.95 per share versus $2.10 per share expected.
— Sales rose by 2.1% to $8.11 billion versus $8.12 billion expected. Organic local-currency sales declined by 2.6% while acquisitions, net of divestitures, increased sales by 5.1%. Foreign currency translation reduced sales by 0.4%.

— Sales grew by 25.4% in Health Care and were flat in Consumer, while it decreased by 6.2% in Transporation and Electronics and 4.8% in Safety and Industrial.
— On a geographic basis, total sales rose 7.4% in the US and 1.2% in Latin America/Canada, while it declined 2% in EMEA and 1.7% in the Asia Pacific.
— Looking ahead into the full year 2020, the company expects earnings in the range of $9.30-9.75 per share. The consensus estimates EPS of $9.61. The organic local-currency sales are anticipated to be flat to 2%.
— The free cash flow conversion is expected to be in the range of 95-105% and return on invested capital is predicted to be 18-21% for the full year 2020.
— 3M announced the next step in its transformation journey, which includes a new global operating model and a streamlined organizational structure. The company initiated a restructuring that will lower about 1,500 positions, spanning all business groups, functions and geographies.
— On a pre-tax basis, 3M took a restructuring charge of $134 million in the fourth quarter of 2019. The company expects annual pre-tax savings of $110 million to $120 million, with $40 million to $50 million in 2020.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Infographic: Amazon (AMZN) Q4 2024 earnings beat estimates; sales rise 10%
E-commerce giant Amazon.com Inc. (NASDAQ: AMZN) on Thursday reported higher sales and profit for the fourth quarter of 2024. Earnings also beat analysts' estimates. Net sales increased to $187.8 billion
Philip Morris (PM) delivers strong performance in 4Q24 helped by smoke-free strength
Shares of Philip Morris International Inc. (NYSE: PM) jumped 10% on Thursday after the company delivered better-than-expected earnings results for the fourth quarter of 2024 and provided an encouraging outlook
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue. Net income attributable to shareholders was $72 million or